We next used the DNA isolated from a tumorous section of the FFPE sample of the affected MAP3K6 SNV carrier 1884 (the proband) to screen for additional somatic SNVs or loss of heterozygosity (LOH) within the tumor itself. Here, MAP3K6 is linked to neoplasm.